<DOC>
	<DOC>NCT01051583</DOC>
	<brief_summary>Assess the efficacy of Avastin as an adjunct to Diode Laser cyclophotocoagulation in the treatment of Neovascular Glaucoma.</brief_summary>
	<brief_title>Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma</brief_title>
	<detailed_description>Design: Prospective, comparative interventional case series. Method: Patients were randomly assigned into Group A which were treated with Diode laser cyclophotocoagulation alone, whereas group B received intravitreal Avastin (One milligram = 0.04mL of 25 mg/mL) in conjunction with the Diode Laser. The preoperative data included etiology, mean age; follow up period, and a full ophthalmological examination with emphasis on mean IOP, iris neovascularization, pain and corneal edema.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Neovascular</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Neovascular absolute glaucoma Painful blind eyes Neovascular glaucoma with useful vision or potential for useful vision</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Neovascular glaucoma</keyword>
	<keyword>diode laser</keyword>
	<keyword>cyclophotocoagulation</keyword>
	<keyword>Avastin</keyword>
</DOC>